Strategic Acquisition Alpine Immune Sciences has recently been acquired by Nan Fung Group, which could present opportunities for tailored partnership solutions or integration services to support the expanded corporate structure and growth ambitions.
Funding Milestone The company secured $150 million through a public offering, indicating strong investor confidence; this influx of capital may drive demand for advanced clinical trial management, compliance solutions, or high-tech R&D infrastructure.
Leadership Expansion Recent appointments of high-profile executives such as a Chief Medical Officer and Chief Accounting Officer suggest a focus on strengthening leadership capacity, providing opportunities for executive-focused consulting, executive training, or leadership communication solutions.
Research Innovation As a clinical-stage biotechnology firm collaborating with industry giants like AbbVie, there is potential to offer cutting-edge technology platforms, research tools, or data management solutions tailored to biopharmaceutical R&D environments.
Market Presence With its recent public listing and ongoing funding activities, Alpine Immune Sciences is seeking to enhance its market visibility, presenting avenues for outreach with marketing solutions, investor relations tools, or corporate branding services.
Alpine Immune Sciences, Inc. uses 8 technology products and services including cdnjs, RSS, Twemoji, and more. Explore Alpine Immune Sciences, Inc.'s tech stack below.
| Alpine Immune Sciences, Inc. Email Formats | Percentage |
| First.Last@alpineimmunesciences.com | 46% |
| FLast@alpineimmunesciences.com | 4% |
| First.Last@alpineimmunesciences.com | 46% |
| FLast@alpineimmunesciences.com | 4% |
Biotechnology ResearchUnited States51-200 Employees
Alpine Immune Sciences is now part of Vertex Pharmaceuticals. Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. For more information about Vertex, please visit us at https://www.vrtx.com/. Follow Vertex on LinkedIn for future updates at https://www.linkedin.com/company/vertex-pharmaceuticals/.
Company Overview
Media & News
Funding & FinancialsAlpine Immune Sciences, Inc. has raised a total of $150M of funding over 7 rounds. Their latest funding round was raised on Nov 06, 2023 in the amount of $150M.
Alpine Immune Sciences, Inc.'s revenue is estimated to be in the range of $10M$25M
Funding & FinancialsAlpine Immune Sciences, Inc. has raised a total of $150M of funding over 7 rounds. Their latest funding round was raised on Nov 06, 2023 in the amount of $150M.
Alpine Immune Sciences, Inc.'s revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com